Publicaciones en colaboración con investigadores/as de Aarhus University Hospital (1)

2022

  1. Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials

    Journal of Dermatological Treatment, Vol. 33, Núm. 1, pp. 266-277